Valneva SE (VALN)
NASDAQ·Healthcare·Biotechnology
$5.35
+1.13%
Mkt Cap $903.47M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$18.33
Range $14.00 – $26.00
Implied Upside
+242.6%
Consensus $18.33 vs current $5.35
NASDAQ·Healthcare·Biotechnology
$5.35
+1.13%
Mkt Cap $903.47M
No recent rating data.
Price Target (3 analysts)
$18.33
Range $14.00 – $26.00
+242.6%
Consensus $18.33 vs current $5.35